What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Arch Venture Fund Xiii, LP: large open-market buy of LYEL
$12.5M open-market purchase by Arch Venture Fund Xiii, LP, 10% Owner at Lyell Immunopharma,Inc., filed March 9, 2026. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View LYEL
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyLYEL
$12.74+1.76% today
Arch Venture Fund Xiii, LP · 10% Owner at Lyell Immunopharma,Inc.
$12.5M
Arch Venture Fund Xiii, LP bought $12.5M of LYEL (Lyell Immunopharma,Inc.).
Insider purchase
Transaction details
Arch Venture Fund Xiii, LP, a 10% beneficial owner, reported a $12.5M open-market purchase equal to 4.2% of LYEL's market cap.
Arch Venture Fund Xiii, LP (10% Owner) bought 488,090 shares of LYEL, Lyell Immunopharma,Inc., Healthcare ($297.3M market cap), at $25.61 per share on March 6, 2026 for a total of $12.5M (4.2% of the market cap).
Arch Venture Fund Xiii, LP
10% Owner
Purchase value$12.5M
Shares purchased488,090
Price per share$25.61 per share
- % of market cap
- 4.2%
- Trade date
- March 6, 2026
- Filed
- March 9, 2026
- Filing delay
- 3 days
Permalink https://bluecollarpicks.com/insider-trading/LYEL/buy/770716
Market context
LYEL market snapshot
Current price$12.74
1-day change+1.76%
Market cap$297.3M
SectorHealthcare
Next earningsAugust 10, 2026
$12.74
Current price$12.74
Analyst target$37.17 (+191.7%)
Last enriched June 21, 2026 at 5:00 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Other 10% Owner | Not reported | ||
Sell Officer | $2.5K | ||
Grant Officer | $0 | ||
Cluster Buy 10% Owner | $12.5M | ||
| This filing | Cluster Buy 10% Owner | $12.5M | |
Sell CEO | $174.4K | ||
Sell Officer | $28.9K | ||
Sell Officer | $39.1K | ||
Sell Officer | $2.5K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell Officer | $3.4K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell CEO | $10.1K | ||
Grant CEO | $0 | ||
Grant CEO | $0 | ||
Grant Officer | $0 | ||
Sell Officer | $5.9K | ||
Grant Officer | $0 | ||
Grant Officer | $0 | ||
Sell Officer | $30.3K | ||
Sell Officer | $43.9K | ||
Sell CEO | $76.5K | ||
Sell Officer | $15.3K | ||
Sell CFO | $15.3K | ||
Sell Officer | $10.6K | ||
Sell CFO | $1.4K | ||
Sell Officer | $1.4K | ||
Sell Officer | $972 | ||
Sell CEO | $4.2K | ||
Sell CFO | $1.4K | ||
Sell Officer | $1.4K | ||
Sell Officer | $958 | ||
Sell CEO | $4.1K | ||
Buy Director | $20K | ||
Cluster Buy Director | $115.2K | ||
Cluster Buy CFO | $111.6K | ||
Cluster Buy Director | $94.9K | ||
Cluster Buy CEO | $106.2K | ||
Not reported
Other 10% Owner
$2.5K
Sell Officer
$0
Grant Officer
Cluster Buy 10% Owner
$12.5M
Cluster Buy 10% Owner
$174.4K
Sell CEO
$28.9K
Sell Officer
$39.1K
Sell Officer
$2.5K
Sell Officer
Grant Officer
Grant Officer
$3.4K
Sell Officer
$0
Grant Officer
$0
Grant Officer
$10.1K
Sell CEO
$0
Grant CEO
$0
Grant CEO
$0
Grant Officer
$5.9K
Sell Officer
Grant Officer
$0
Grant Officer
$30.3K
Sell Officer
$43.9K
Sell Officer
$76.5K
Sell CEO
$15.3K
Sell Officer
$15.3K
Sell CFO
$10.6K
Sell Officer
$1.4K
Sell CFO
$1.4K
Sell Officer
$972
Sell Officer
$4.2K
Sell CEO
$1.4K
Sell CFO
$1.4K
Sell Officer
$958
Sell Officer
$4.1K
Sell CEO
$20K
Buy Director
$115.2K
Cluster Buy Director
$111.6K
Cluster Buy CFO
$94.9K
Cluster Buy Director
$106.2K
Cluster Buy CEO
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.